203 related articles for article (PubMed ID: 27537859)
1. Emerging drugs for the treatment of kidney disease-induced anemia.
Malyszko J; Malyszko JS
Expert Opin Emerg Drugs; 2016 Sep; 21(3):315-30. PubMed ID: 27537859
[TBL] [Abstract][Full Text] [Related]
2. Investigational therapies for renal disease-induced anemia.
Schmid H; Jelkmann W
Expert Opin Investig Drugs; 2016 Aug; 25(8):901-16. PubMed ID: 27122198
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantages.
Mima A
Eur J Pharmacol; 2021 Dec; 912():174583. PubMed ID: 34678238
[TBL] [Abstract][Full Text] [Related]
4. Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval?
Locatelli F; Del Vecchio L
Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):339-344. PubMed ID: 29846220
[TBL] [Abstract][Full Text] [Related]
5. Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.
Del Vecchio L; Locatelli F
Expert Opin Investig Drugs; 2018 Jul; 27(7):613-621. PubMed ID: 29975110
[TBL] [Abstract][Full Text] [Related]
6. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease.
Malyszko J; Malyszko JS; Matuszkiewicz-Rowinska J
Expert Opin Ther Targets; 2019 May; 23(5):407-421. PubMed ID: 30907175
[TBL] [Abstract][Full Text] [Related]
8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
9. Current and future chemical therapies for treating anaemia in chronic kidney disease.
Locatelli F; Del Vecchio L; Luise MC
Expert Opin Pharmacother; 2017 Jun; 18(8):781-788. PubMed ID: 28443351
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease.
Hasegawa S; Tanaka T; Nangaku M
Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):331-338. PubMed ID: 30067604
[TBL] [Abstract][Full Text] [Related]
11. New Treatment Approaches for the Anemia of CKD.
Bonomini M; Del Vecchio L; Sirolli V; Locatelli F
Am J Kidney Dis; 2016 Jan; 67(1):133-42. PubMed ID: 26372086
[TBL] [Abstract][Full Text] [Related]
12. Anemia in conventional hemodialysis: Finding the optimal treatment balance.
Hasegawa T; Koiwa F; Akizawa T
Semin Dial; 2018 Nov; 31(6):599-606. PubMed ID: 29909605
[TBL] [Abstract][Full Text] [Related]
13. It's time to compare anemia management strategies in hemodialysis.
Coyne DW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.
Kaplan JM; Sharma N; Dikdan S
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29382128
[TBL] [Abstract][Full Text] [Related]
15. Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease.
Solak Y; Cetiner M; Siriopol D; Tarim K; Afsar B; Covic A; Kanbay M
Blood Purif; 2016; 42(2):160-7. PubMed ID: 27318465
[TBL] [Abstract][Full Text] [Related]
16. Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies.
Del Vecchio L; Locatelli F
Expert Rev Hematol; 2014 Aug; 7(4):495-506. PubMed ID: 25025373
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease-associated anemia: new remedies.
Del Vecchio L; Cavalli A; Tucci B; Locatelli F
Curr Opin Investig Drugs; 2010 Sep; 11(9):1030-8. PubMed ID: 20730698
[TBL] [Abstract][Full Text] [Related]
18. New alternatives in anemia treatment: biosimilars and HIF stabilizers.
Krishnan M; Nissenson AR
Nephrol News Issues; 2014 May; 28(6):24-8. PubMed ID: 24908823
[No Abstract] [Full Text] [Related]
19. Emerging drugs for treatment of anemia of chronic kidney disease.
Magwood JS; Lebby A; Chen B; Kessler S; Norris L; Bennett CL
Expert Opin Emerg Drugs; 2013 Dec; 18(4):421-9. PubMed ID: 24033253
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis and treatment of anemia in chronic kidney disease].
Nangaku M
Rinsho Ketsueki; 2017; 58(10):1860-1863. PubMed ID: 28978825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]